Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Open Source Software
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Peripheral CD5+ B cells in antineutrophil cytoplasmic antibody-associated vasculitis.
Rituximab for the treatment of relapses in antineutrophil cytoplasmic antibody-associated vasculitis.
Outcomes of nonsevere relapses in antineutrophil cytoplasmic antibody-associated vasculitis treated with glucocorticoids.
Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type.
Corticosteroids in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Effect of Disease Activity, Glucocorticoid Exposure, and Rituximab on Body Composition During Induction Treatment of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Reducing glucocorticoid duration in ANCA-associated vasculitis: A pilot trial.
Management of ANCA associated vasculitis.
Topic modeling to characterize the natural history of ANCA-Associated vasculitis from clinical notes: A proof of concept study.
Anti Neutrophil Cytoplasmic Antibody Associated Vasculitis